Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphomaIn: Blood Advances Jg. 6 (2022) Nr. 23, S. 5995 - 6004Online Volltext: dx.doi.org/ (Open Access)
-
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell LymphomaIn: Clinical Lymphoma, Myeloma & Leukemia Jg. 22 (2022) Nr. 6, S. 382 - 392Online Volltext: dx.doi.org/ (Open Access)
-
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma : International Metabolic Prognostic IndexIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 21, S. 2352 - 2360Online Volltext: dx.doi.org/ (Open Access)
-
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma : An experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)In: British Journal of Haematology Jg. 196 (2022) Nr. 3, S. 606 - 616Online Volltext: dx.doi.org/ (Open Access)
-
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ MethodIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 37 - 42Online Volltext: dx.doi.org/ (Open Access)
-
Interim PET in Diffuse Large B-Cell LymphomaIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 8, S. 1068 - 1074Online Volltext: dx.doi.org/ (Open Access)
-
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 23, S. 2605 - 2616Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialIn: Hematological Oncology (2020)Online Volltext: dx.doi.org/ (Open Access)
-
Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))In: European Journal of Cancer (EJC) Jg. 136 (2020) S. 207 - 208Online Volltext: dx.doi.org/ (Open Access)
-
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trialIn: European Journal of Cancer (EJC) Jg. 124 (2020) S. 25 - 36Online Volltext: dx.doi.org/
-
Etoposide combined with FLAG salvage therapy is effective in multiple relapsed / refractory acute myeloid leukemiaIn: Acta Haematologica Jg. 143 (2020) Nr. 5, S. 438 - 445Online Volltext: dx.doi.org/ (Open Access)
-
FDG-PET imaging for hodgkin and diffuse large b-cell lymphoma : an updated overviewIn: Cancers Jg. 12 (2020) Nr. 3, S. 601Online Volltext: dx.doi.org/ (Open Access)
-
Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies : results from the ‘Aftercare in Blood Cancer Survivors’ (ABC) studyIn: International Journal of Clinical Oncology Jg. 25 (2020) Nr. 6, S. 1187 - 1194Online Volltext: dx.doi.org/ (Open Access)
-
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyIn: Cancer Medicine Jg. 99 (2020) Nr. 22, S. 8386 - 8396Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphomaIn: Leukemia and Lymphoma Jg. 61 (2020) Nr. 6, S. 1372 - 1379Online Volltext: dx.doi.org/
-
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationIn: Data in Brief Jg. 28 (2020) 104976Online Volltext: dx.doi.org/ (Open Access)
-
Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibitionIn: Vaccine Jg. 37 (2019) Nr. 44, S. 6682 - 6687Online Volltext: dx.doi.org/
-
Characteristics of the relationship between MTV and survival in diffuse large B-cell lymphoma : A PETRA consortium study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S357Online Volltext: dx.doi.org/ (Open Access) -
Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 1696 - 1696Online Volltext: dx.doi.org/ (Open Access) -
Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL TrialIn: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4188 - 4188Online Volltext: dx.doi.org/ (Open Access)